Trial Profile
Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantation
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 05 Sep 2014
Price :
$35
*
At a glance
- Drugs Liver cell therapy (Primary)
- Indications Hepatic encephalopathy; Liver failure
- Focus Therapeutic Use
- Sponsors Cytonet
- 05 Sep 2014 New trial record